Danijel Svec

Senior Cell Line Development Associate & Project Team Leader at ExcellGene SA

Speaker

Danijel Svec earned a Master’s degree in Molecular Biotechnology from the University of Zagreb, Croatia, in 2020. He completed his research at the Ruđer Bošković Institute, Croatia’s leading scientific institution in natural and biomedical sciences, under the mentorship of Prof. Andreja Ambriović Ristov in the Laboratory for Cell Biology and Signalling. During this time, he gained expertise in transient gene expression, gene silencing, and viral production. His thesis contributed to a scientific publication, providing new insights into the viral entry mechanism of human Adenovirus AdV26 and the development efficiency of the Ad26-based vaccine vector platform.

In 2021, Danijel joined ExcellGene as a Research Associate, where he has focused on the pre-clinical development of HEK-based processes for AAV production. He further advanced HEK-based cell line development and manufacturing process. Due to his efforts, the HEK-based platform was successfully incorporated into ExcellGene’s operational activities in 2022, delivering stable HEK cell lines with yields of up to 7 g/L, significantly advancing the HEK-based manufacturing. Danijel now serves as the Senior CLD Scientist and Project Team Leader, overseeing HEK-related activities.